Cellular Biomedicine Group Announces a $43.13 Million Strategic Investment from Dangdai International Group Co., Limited, a wholly owned Hong Kong Subsidiary of Wuhan Dangdai Science & Technology Industries Group Inc.SHANGHAI, ...
NEW YORK, April 7, 2015 /PRNewswire/ — Attorney Advertising — Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of the securities of Cellular Biomedicine Group ...
Los Angeles, March 12, 2015 -- StockWatchIndex today has added Cellular Biomedicine Group (CBMG - NasdaqCM) to its WatchIndex on stockwatchindex.com. CBMG has had an absolute exceptional run since we initiated ...
SWI Initiates Coverage onCellular Biomedicine Group NASDAQ:CBMG Presents at the 8th Annual OneMedForum7th Annual BioTech Showcase in San FranciscoInvesting in the Immuno-Oncology RevolutionWide World of Stocks Broadcast CEO Interview Cellular Biomedicine Group, Inc. (NASDAQ:CBMG) is a ...
